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Genetic Epidemiology of Glucose-
6-Dehydrogenase Deficiency in the 
Arab World
C. George Priya Doss1, Dima R. Alasmar2, Reem I. Bux2, P. Sneha1, Fadheela Dad Bakhsh2,  
Iman Al-Azwani2, Rajaa El Bekay3 & Hatem Zayed2
A systematic search was implemented using four literature databases (PubMed, Embase, Science Direct 
and Web of Science) to capture all the causative mutations of Glucose-6-phosphate dehydrogenase 
(G6PD) deficiency (G6PDD) in the 22 Arab countries. Our search yielded 43 studies that captured 33 
mutations (23 missense, one silent, two deletions, and seven intronic mutations), in 3,430 Arab patients 
with G6PDD. The 23 missense mutations were then subjected to phenotypic classification using in silico 
prediction tools, which were compared to the WHO pathogenicity scale as a reference. These in silico 
tools were tested for their predicting efficiency using rigorous statistical analyses. Of the 23 missense 
mutations, p.S188F, p.I48T, p.N126D, and p.V68M, were identified as the most common mutations 
among Arab populations, but were not unique to the Arab world, interestingly, our search strategy 
found four other mutations (p.N135T, p.S179N, p.R246L, and p.Q307P) that are unique to Arabs. These 
mutations were exposed to structural analysis and molecular dynamics simulation analysis (MDSA), 
which predicting these mutant forms as potentially affect the enzyme function. The combination of the 
MDSA, structural analysis, and in silico predictions and statistical tools we used will provide a platform 
for future prediction accuracy for the pathogenicity of genetic mutations.
G6PD is a housekeeping enzyme that is important in the pentose phosphate pathway (PPP) and essential for basic 
cellular function. G6PD also aids in producing compounds to prevent build-up of reactive oxygen species (ROS) 
within red blood cells1. The protein exists in both monomer and tetramer forms with the monomer consisting of 
515 amino acids with a molecular weight of 59.625 kDa. The prevalence of G6PDD has been increasing through 
independent mutational events in different geographical areas where prevalence rate of malaria is currently or was 
previously endemic2. The clinical manifestations of G6PDD vary from asymptomatic individuals to patients with 
acute haemolytic anaemia, chronic non-spherocytic haemolytic anaemia, drug-induced haemolytic anaemia, 
favism, and neonatal jaundice3. G6PD mutations are classified by the WHO into five classes (Class I-V) according 
to their effect on the activity of the enzyme, where Class I is the severest, and Class V is normal4.
G6PDD is one of the most prevalent genetic diseases in the Arab countries; it is reported to have a high prev-
alence in Saudi Arabia (39.8%), Syria (30%), and Oman (29%) compared to other Arab countries5–7. More than 
300 different mutations have been reported in the G6PD gene8; to date, the Human Gene Mutation Database 
(www.hgmd.cf.ac.uk/) has reported 202 mutations, with 68 pathogenic mutations that belong to Class I (WHO). 
The Mediterranean mutation (p.S188F) is the most prevalent among Arabs, with 90% frequency in Bahraini 
patients9–11, 87.8% in Northern Iraqi males, 74.2% in Kuwait, and 53.6% in Jordan12,13. Limited studies have inves-
tigated the incidence of G6PD mutations and their functional role in causing disease among Arab countries. 
In this study, we performed a systematic search to identify the mutations in the G6PD gene that are prevalent 
among Arab patients with GPDD. We found four mutations circulating among Arab populations that are shared 
with other ethnic groups, and four unique mutations that are distinctive to Arab populations. In silico prediction 
scores, structural analysis, and MDSA were performed to investigate the genotype-phenotype correlations in the 
patients harbouring these mutations. The results obtained from combination of different computational methods 
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matched the WHO classification of these mutations, providing a practical evidence of the importance of the com-
putational tools in predicting the effects of mutations on protein function.
Results
Our search strategy yielded 553 citations; of which 43 eligible articles were thoroughly screened and included 
in this study (Supplementary Fig. S1). A total of 3,430 Arab patients with G6PDD were captured, harbouring 
33 mutations (23 missense mutations, one silent mutation, two deletions, and seven intronic mutations) (Figs 1 
and 2). Tunisia, Saudi Arabia, and Jordan had most of the mutations circulated in the Arab countries. The 23 
missense mutations were subjected to in silico prediction analysis to analyse the genotype-phenotype correla-
tion of Arab patients with G6PDD (Supplementary Table S1). Out of the 23 missense mutations tested, 20, 18, 
18, 17, and 18 were designated as disease (SNPs&GO), probably damaging (PolyPhen-2), deleterious (SIFT), 
effect (SNAP2), and functional impact (Mutationassessor), respectively. Various statistical parameters as shown 
in the methods were used to evaluate the performance of the 5 in silico prediction methods. Mutationassessor, 
SNPs&GO, PolyPhen-2 and SNAP2 scored best in terms of sensitivity/TPR with a score of 1. Of the five in silico 
methods, SNPs&GO was predicted with least FPR score of (0.33) which illustrates the better effectiveness in 
predicting the mutational effect as neutral. SNPs&GO (0.86) performed best in terms of accuracy followed by 
PolyPhen-2 & SIFT with a score of (0.78) and Mutationassessor & SNAP2 with a score of (0.74). All the predic-
tions tools exhibited MCC value greater than 0, and none of the tools exhibited a negative value, indicating that 
the obtained results were more reliable and accurate. Overall observed results from the statistical analysis we 
conclude SNPs&GO as the best in silico tool in the prediction of deleterious mutations (Supplementary Table S2).
Genotype-phenotype correlations. The frequency of the common mutations circulating among Arab 
patients with G6PDD was calculated by dividing the number of patients harbouring each mutation by the 
total number of patients, the p.S188F mutation was found to have highest prevalence among Arabs followed 
by p.N126D, p.V68M, and p.I48T mutations (Supplementary Table S3). These four mutations are not unique 
Figure 1. Mutations observed in the intronic and exonic regions of G6PD among the Arab populations. 
Figure 2. Distribution of missense mutations in the Arab world (green color) were marked in normal and 
inverted triangular symbols. The Map is created using the African continent (Africa’s regional Thumbnail) 
free map product (http://english.freemap.jp/item/africa/africa_1.html) licensed under the Creative Commons 
Attribution 3.0 unported (CC BY 3.0) license.
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to Arabs; however, p.N135T, p.S179N, p.R246L, and p.Q307P mutations were identified as unique mutations to the 
Arab populations (Supplementary Table S1). Phenotypic classification using in silico tools were compared with the 
WHO pathogenicity reference scale to validate their prediction accuracy. Of the 23 missense mutations, 3 mutations 
were excluded as they were not reported by the WHO classifications. The rest 20 mutations are classified as 5% class 
I (severe), 55% class II (severe) and 40% class III (mild) by the WHO classification (Supplementary Table S1). The 
mutation classified as WHO class I (severe) was identified as pathogenic by SNPs&GO, PolyPhen-2, Mutationassessor, 
SNAP2 and SIFT. Among the 11 mutations classified as WHO Class II (severe); 10, 9, 8, 9 and 10 mutations were 
identified as pathogenic and the remaining as neutral by SNPs&GO, PolyPhen-2, Mutationassessor, SNAP2, and SIFT. 
Similarly for the 8 mutations classified as WHO Class III (mild); 6, 5, 5, 4 and 5 mutations were identified as pathogenic 
and the remaining as neutral by SNPs&GO, PolyPhen-2, Mutationassessor, SNAP2, and SIFT. These observed results 
conclude the tool SNPs&GO had higher percentage of matching towards both WHO Class II and Class III in predict-
ing the mutations as disease causing or pathogenic. The common and unique Arab mutations were categorized and 
compared with the WHO classification as either Class II or Class III (Table 1). In conclusion, it seems to be a correlation 
between the in silico tool prediction scores and WHO reference scale in classifying the three mutations (common- 
p.S188F & unique- p.R246L, and p.Q307P) as Class II (severe), three common mutations p.N126D, p.V68M, and 
p.I48T as Class III (mild) and the remaining two unique mutations p.N135T and p.S179N as ‘not reported’.
Conservation analysis. Sequence conservation analysis was performed primarily by building multiple 
sequence alignment (MSA) using Clustal Omega. The protein sequence of G6PD in humans is mostly conserved 
among different species, including mice, rat, hamster, bosin, and human (Supplementary Fig. S2). Subsequently, 
the obtained MSA was submitted as the input file to ConSurf tool to calculate the evolutionary conserved regions 
in common and unique mutational positions in G6PD (Supplementary Fig. S3). The observed results indicate 
amino acid position I48 as the highly conserved followed by V68, N126, and S188. When assessing the unique 
mutations, the amino acid positions N135 and S179 were not as highly conserved as the amino acids R246 and 
Q307. As a next step, we assessed the solvent accessibility property of each amino acid position using ConSurf 
results. In case of positions where common mutations are occurring, ConSurf predicted I48 and V68 in buried 
region and N126 and S188 in exposed region. Meanwhile, all four positions of unique mutations were observed in 
the exposed region may have functional effects as predicted by ConSurf (Supplementary Fig. S3).
MDSA. The native and the 8 mutant protein structures were subjected to MDSA showed stabilization at 30 ns. 
To have a better uniqueness in the structural and functional analysis, simulation analysis of the trajectory files 
were compared between the common and unique mutations. The resultant trajectory files were used to analyse 
the changes in the protein structure and function.
Common mutations. The Root Mean Square deviation (RMSD) results showed a large deviation pattern at 
the beginning of the simulation, which might be due to the initial strong kinetic shock experienced by the system. 
The native protein and mutant p.N126D showed comparable pattern of deviation between ~0.33 nm and ~0.35 nm, 
followed by the mutant p.I48T with slight increase in deviation pattern between ~0.38 nm and ~0.41 nm respectively. 
Whereas, the mutants p.V68M and p.S188F, exhibited similar deviation pattern between ~0.42 nm and 0.45 nm, 
which is slightly higher than the native and mutant p.N126D. However, the complete convergence was observed 
for all the molecules at the end of 30 ns (Fig. 3a). In Root Mean Square Fluctuation (RMSF) analysis higher residual 
fluctuation of ~0.9 nm was observed in the mutant p.V68M. Whereas the native and other mutant proteins showed 
a similar fluctuation with maximum of ~0.7 nm (Fig. 4a). To verify the above results, the number of intramolecular 
hydrogen bonds formed within the protein was calculated using g_hbond (Fig. 5a). Among these mutants, p.N126D 
participated in the higher number of hydrogen bonds formation, followed by p.S188F and p.V68M respectively. The 
mutant p.I48T showed a constant number of hydrogen bonds formation. Solvent Accessible Surface Area (SASA) 
of the protein suggested that there is a loss of balance in the hydrophilic nature of the mutant p.S188F with a lesser 
SASA value (Fig. 6a), the mutant p.V68M showed higher SASA values, and the mutant p.I48T showed similar SASA 
values as that of the native. These results suggest that the mutants’ p.S188F and p.V68M exhibited higher structural 
differences from that of native protein when compared to the other mutants.
Unique mutations. Similar analysis was performed for the unique mutations by comparing the mutants 
with the native protein. The RMSD plots predicted the mutant p.R246L with a higher RMSD of ~0.45 nm~0.42 nm 
at 30 ns. Whereas, the other mutants and native protein showed similar minimal deviation over the period of 
30 ns (Fig. 3b). As for the common mutations, the convergence was observed at the end of 30 ns simulation for 
the unique mutations. From the RMSF plots, residual fluctuation in all the mutants was similar to that of native 
with a fluctuation of ~0.75 nm, except mutant p.R246L exhibited highest residual fluctuation of 0.85 nm (Fig. 4b). 
Further, number of intramolecular hydrogen bonds formed within the protein was analysed. The mutant p.R246L 
was involved in the least participation towards hydrogen bonds formation, followed by p.S135T. The p.Q307P 
mutant protein participated in higher number of intramolecular hydrogen bonds formation when compared to 
the native. On the other hand, the mutant p.S179N showed a similar number of intramolecular hydrogen bonds 
formation as of the native protein (Fig. 5b). Finally, SASA analysis was carried out for all the mutant proteins 
where the mutant p.R246L showed decreased SASA values, which further indicate that the mutant p.R246L could 
have lost contact with surrounding solvent molecules (Fig. 6b). Based on the above observation we conclude that 
the mutant p.R246L exhibited larger structural differences among the four unique mutations.
Discussion
This present study focuses on the mutations that are causing the G6PDD among Arab populations (Fig. 2 and 
Supplementary Table S1). A comparison between the mutations in Arabs and Asians showed that most of the 
mutations responsible for the G6PDD shared among the two ethnic groups, which could be due to the long 
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history of admixture among the two ethnic groups. These mutations were also shared with other ethnic groups, 
for example, the most frequent mutation among Arabs, p.S188F, was also frequently reported in Greece, south-
ern Italy, Spain, Bulgaria, Romania, Turkey, and Israel14–17. We identified the most frequent mutations (p.S188F, 
p.V68M, p.I48T and p.N126D) and unique mutations (p.N135T, p.S179N, p.R246L, and p.Q307P) circulated 
among Arabs. Analyzing the effects of each mutation on the protein’s structure and function is very crucial in 
large scale analysis which is laborious and time-consuming by experimental methods. In recent years many stud-
ies have focused on the importance of in silico prediction methods in analyzing the effects of mutations on protein 
function18–21. Generally, these methods make their predictions based on sequence and structured based infor-
mation using physiochemical properties and are benchmarked by the curators with the known datasets and per-
formed well22,23. Subsequently, in the current study, we have used 5 in silico tools to estimate the pathogenic effect 
of the mutations and further compared with the WHO severity classification scale as a reference. The in silico  
prediction tools reported p.S188F, p.R246L, and p.Q307P mutations to be severe, whereas the p.I48T, p.V68M, 
Figure 3. Root Mean Square Deviation (RMSD) Analysis (a) RMSD of the Common mutants and native. Color 
Scheme Native (Black), p.S188F (Red), p.N126D (Blue), p.V68M (Green), and p.I48T (Yellow). (b) Root Mean 
Square deviation of the unique mutants and native. Color Scheme Native (Black), p.S179N (Red), p.Q307P 
(Blue), p.R246L (Green), and p.S135T (Yellow).
Type Mutants Predicted Deleterious by in silico tools WHO classification
Common mutations
p.I48T SNPs&GO, PolyPhen-2, and Mutationassessor Class III (Mild)
p.V68M SNPs&GO, PolyPhen-2, Mutationassessor, and SNAP2 Class III (Mild)
p.N126D None of the tools predicted effect Class III (Mild)
p.S188F SNPs&GO, PolyPhen-2, SNAP2, and SIFT Class II (Severe)
Unique mutations
p.N135T SNAP2, and Mutationassessor Not Reported
p.S179N SNPs&GO, PolyPhen-2, Mutationassessor, SNAP2, and SIFT Not Reported
p.R246l SNPs&GO, PolyPhen-2, Mutationassessor, SNAP2, and SIFT Class II (Severe)
p.Q307P SNPs&GO, PolyPhen-2, Mutationassessor, SNAP2, and SIFT Class II (Severe)
Table 1.  In silico prediction result and their corresponding WHO classification of common and unique 
mutations in G6PD.
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and p.N126D mutations as mild, which were in consistent with the WHO classification for Class II and Class III 
severity scale for the G6PD mutations, respectively. The p.N135T and p.S179N mutations were predicted to affect 
the function of the G6PD enzyme (Supplementary Table S1) but were not assigned to any WHO classification 
(Table 1). The p.N126D and p.V68M mutations belong to the same haplotype and therefore always inherited 
together, causing a deleterious effect on the function of the G6PD enzyme24.
An extensive study that combines and elucidates the results from a systematic search with structural analysis 
helps in understanding the impact of mutations on much broader perspectives like protein stability and flex-
ibility. The protein structure stability plays a predominant role in maintaining the functionality of a protein25. 
A mutation can affect the protein stability (both destabilizing and over stabilizing) leading to deterioration of the 
protein function through physico-chemical properties changes of the mutant amino acids (charge, size, hydro-
phobicity, hydrogen bonds)26. In recent years, MDSA has proved to be a powerful tool in elucidating the changes 
in a macromolecule at an atomistic level, thereby rendering better prediction results27–30. In this context, we seg-
regated the common and unique mutations circulated among Arab patients with G6PDD to analyze the potential 
mutational impact on the function of G6PD enzyme using MDSA and local surrounding residual changes within 
4 Å (Fig. 7a–p). Consequently, various analyses for the trajectories were performed to support our findings. The 
mutants p.S188F and p.V68M showed the highest deviation followed by the mutant p.N126D in the RMSD plots 
(Fig. 3a); a higher RMSD value predicts a decrease in the stability of protein structure31. To analyse the possi-
ble reason behind the change in the stability, other parameters such as the number of intramolecular hydrogen 
bonds formation, and SASA were elucidated. While calculating the number of intramolecular hydrogen bonds 
formed within the protein, reduction in a number of hydrogen bonds formations was observed in the mutant 
p.S188F (Fig. 5a). The decrease in hydrogen bonds in the mutant p.S188F can be due to the substitution of the 
amino acid with different physiochemical properties: serine being a polar amino acid actively participates in 
hydrogen bond formation, subsequently this nature is lost due to a substitution with a non-polar amino acid 
phenylalanine (Fig. 7g and h). Polar amino acids are commonly present in the exposed regions of the protein; 
any mutations in this region are very likely to affect the protein’s function32. Since S188 is present in the exposed 
region (Supplementary Fig. S3), we assessed both serine and phenylalanine contribution towards solvent inter-
action using SASA analysis (Fig. 6a), interestingly we observed a reduction in the SASA value in the presence 
of phenylalanine compared to serine, explaining a loss in the contact with the surrounding solvent which may 
Figure 4. Root Mean Square Fluctuation (RMSF) analysis (a) RMSF of the common mutants and native. Color 
Scheme Native (Black), p.S188F (Red), p.N126D (Blue), p.V68M (Green), and p.I48T (Yellow). (b) RMSF of the 
unique mutants and native. Color Scheme Native (Black), p.S179N (Red), p.Q307P (Blue), p.R246L (Green), 
andp.S135T (Yellow).
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further interfere with the functioning of p.S188F mutant protein. Similarly, in case of mutant p.V68M, the substi-
tuted amino acid methionine is a larger amino acid (M.W.: 131.21 Da) than the native amino acid valine (M.W.: 
99.14 Da) and found to be located on the beta-sheets of the protein (Fig. 7c and d). Beta-sheets are known to be 
with rich hydrogen bonds between the protein strands, therefore mutations that occur in the beta-sheets are likely 
to interfere with hydrogen bond formation, which was observed in the mutant p.V68M (Fig. 5a). We also found 
deviations with the mutant p.I48T, whereas isoleucine, a hydrophobic amino acid, tends to orient towards the 
interior of the protein molecule, whereas, threonine a hydrophilic amino acid tends to lie in the outer region of 
the protein. Hydrophobic residues most often reside in the buried region of the protein, leading to a larger gain 
in stability than the burial of hydrophilic residues33. This decrease in stability was observed with higher RMSD 
values (Fig. 3a). Notably, most of the disease-related mutations were found to have an effect on the stability rather 
than the functioning of the protein34. Substitution of isoleucine (hydrophobic) in the buried region with threonine 
(hydrophilic) might induce unfavourable interaction with the neighboring hydrophobic amino acid (leucine 43) 
leading to a change in folding patterns (Fig. 7a and b). In the mutant p.N126D, aspartic acid introduces a negative 
charge, which allows the formation of hydrogen bonds with other nearby positively charged amino acids and 
consequently, increase in number of hydrogen bonds formation (Fig. 7e and f) which showed correlation with 
MDSA (Fig. 5a).
The unique mutation p.R246L was the most deleterious and exhibited the highest RMSD values (Fig. 3b) with 
few hydrogen bonds formation (Fig. 5b). Arginine is a hydrophilic amino acid that tends to be on the surface of 
the protein. A change in hydrophobic to hydrophilic nature of an amino acid in the buried region might lead to 
stability change and function of the protein35. Arginine interacts with the solvent and increases the stability; fur-
ther substitution with a hydrophobic amino acid (leucine) might leads to destabilization which were consistent 
with findings from RMSD and hydrogen bond analysis (Figs 3b and 5b). In the mutant p.Q307P, glutamine, a 
polar amino acid present on the surface, is replaced by the substitution of a non-polar (proline) amino acid, which 
leads to the structural changes36. Polar amino acids present on the surface tend to interact with the surrounding 
solvent molecules. Substitution with proline induce interactions with polar amino acid tyrosine (Tyr482), sub-
sequently changes the interaction pattern of the protein (Fig. 7o and p). The other two mutants, p.N135S, and 
p.S179N show similar dynamic activity as that of the native protein, which were not reported by the WHO classi-
fication. Hence from the observed MDSA results and the physiochemical changes, we conclude that the p.S188F 
(common) and p.R246L (unique) mutations may have an effect on the stability of the protein.
Figure 5. Hydrogen Bond Analysis (a) Hydrogen bond analysis of common mutants and native. Colour 
Scheme Native (Black), p.S188F (Red), p.N126D (Blue), p.V68M (Green), and p.I48T (Yellow). (b) Hydrogen 
bond analysis of the unique mutants and native. Color Scheme Native (Black), p.S179N (Red), p.Q307P (Blue), 
p.R246L (Green), and p.S135T (Yellow).
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Conclusion
In summary, we have comprehensively collected, systematically analysed, and elucidated the structural changes 
that occurred upon mutations in G6PD using high end computational approach. We mapped all the mutations 
circulated in Arab patients with G6PDD through systematic search of four different databases. We found 33 
mutations (23 missense mutations, one silent mutation, two deletions, and seven intronic mutations); of these, 
the most frequent mutations are p.I48T, p.V68M, p.N126D, and p.S188F, which are shared with Asians and 
Europeans, and the mutations p.N135T, p.S179N, p.R246L and p.Q307P were unique to Arabs. It is suspected 
that there are more mutations that are unique to Arabs to be discovered, due to the prevalence of consanguineous 
and endogamous marriage among Arabs and the considerable number of undiagnosed patients due to the lack of 
comprehensive health care system, which gives Arabs a distinctive genetic profile compared with other ethnicities 
in terms of susceptibility to G6PDD. A systematic review has gained importance in clinical healthcare settings 
to understand the plausible mutations present in a population. This study demonstrates the usefulness of com-
bination of the structural and computational analysis in understanding the genotype-phenotype correlation of 
the disease and paves the way for the application of user friendly tools in variant assessment in clinical molecular 
genetic diagnostics.
Methods
Study Selection. A systematic search was performed using four databases (PubMed, Embase, ScienceDirect, 
and Web of Science) to capture the circulated mutations among Arab patients with G6PDD in the 22 Arab coun-
tries from inception to May, 2016. The studies were then selected based on the following criteria: (1) published 
as a primary research paper in a peer-reviewed journal, (2) only Arab patients residing in Arab countries, and 
(3) Arab patients that were diagnosed with G6PDD. Combinations of search terms were restricted to “G6PD 
deficiency” OR “Glucose-6-phosphate deficiency” OR “G6PDD”, together with the name of each Arab country 
individually OR the terms: “Gulf ” OR “GCC” OR “Arab”.
In silico predictions. The pathogenicity of the 23 missense mutations among the Arab population was 
assessed using five in silico prediction tools, namely, SNAP237 (https://www.rostlab.org/services/snap/), SIFT38 
(http://sift.jcvi.org), PolyPhen-239 (http://genetics.bwh.harvard.edu/pph2/), SNPs&Go40 (http://snps-and-go.bio-
comp.unibo.it/snps-and-go/), and Mutationassessor41 (http://mutationassessor.org/).
Figure 6. Solvent-Accessible Surface Area analyses (SASA) (a) SASA of Common mutants and native mutants. 
Color Scheme Native (Black), p.S188F (Red), p.N126D (Blue), p.V68M (Green), and p.I48T (Yellow). (b) SASA 
of the unique mutants and native. Color Scheme Native (Black), p.S179N (Red), p.Q307P (Blue), p.R246L 
(Green), and p.S135T (Yellow).
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Figure 7. PyMOL visualization to compare the native and mutant amino acids. (a) native I48, (b) mutant 
p.I48T, (c) native V68, (d) mutant p.V68M, (e) native N126, (f) mutant p.N126D, (g) native S188, (h) mutant 
S188F, (i) native N135, (j) mutant p.N135T, (k) native S179, (i) mutant p.S179N, (m) native R246, (n) mutant 
p.R246L, (o) native Q307, (p) mutant p.Q307P. This visualization helps to predict the possible changes occurred 
upon mutation. Major differences observed are discussed below. In p.I48T, there is gain of polar contacts 
with Tyr49 and Leu43. Gain of contact with a hydrophobic amino acid such as Leucine further changes the 
orientation of the amino acid. P.V68M, where there the mutant (M) is larger than the native (V). In p.S188F, 
there is loss of polar contact indicating loss of stability. Loss of contacts are also observed in p.N125T mutant. 
Arginine (R) at 246th position is in surface, further substitution with hydrophobic amino (L), destabilizes the 
protein structure. In mutant p.Q307P, a larger amino acid is substituted with much smaller Proline (P) and 
forming contacts with Tyr 482 (polar amino acid) changes the orientation of the mutant amino acid.
www.nature.com/scientificreports/
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Statistical analysis. A statistical analysis was performed to measure the consistency of the in silico predic-
tion tools using parameters such as PPV (positive predictive value), NPV (negative predictive value), sensitivity/
TPR (true positive rate), specificity/TNR (true negative rate), FPR (false positive rate), FNR (false negative rate), 
ACC (accuracy), and MCC (Matthews correlation coefficient). Mutations with deleterious scores predicted by 
the in silico tools were designated as ‘positive’ and those with non-deleterious scores were designated as ‘negative’. 
True Positive (TP), True Negative (TN), False Positive (FP), and False Negative (FN) were calculated for each 
mutation by comparing the tool results and the prevalence, which was also used to calculate the above mentioned 
parameters for the 5 in silico tools. The reliability of the prediction can be determined by Matthews correlation 
coefficient (MCC), where a score of 1 indicates the best reliability, − 1 indicates the worst reliability and a score 
near to 0 indicates that the prediction is a result of chance42. Based on the results obtained from the in silico tools, 
the mutations that could have an effect on the protein were selected. Furthermore, the mutants with the most 
deleterious effect and higher prevalence in Arab countries were categorized as common and unique mutations.
Structure and conservation analysis. The crystal structure of the protein was retrieved from the Protein 
Data Bank (PDB) with ID: 2BHL43 and mutation analysis was performed using SwissPDB Viewer. A cross-species 
multiple sequence alignment (MSA) was performed for the G6PD sequence from mice, rat, hamster, Bosindicus 
(Bosin), and human. The ConSurf conservation tool was used to precisely assign conservation scores for each amino 
acid across species44.
MDSA. The protein structures of the native and mutant were used as the initiation of Molecular Dynamics 
Simulation. The simulation for the protein structure was performed using Gromacs 4.5.645 package with 
GROMOS96 43a1 force field46. Initially, the protein structure was solvated in a cubic box with 10 Å radii. Further, 
using “genion” tool, the system was neutralised by adding Chlorine ions as there was an overall positive charge. 
Subsequently, the system was energy minimised until a lowest energy of 1000 kJ was obtained. This energy min-
imised system was equilibrated by subjecting to NVT and NPT for 50000 steps each. Finally, a production MD 
step was performed for 30 ns (nanoseconds). Van der Waals interactions were modelled using 6–12 Lennard-Jones 
potentials, with a 1.4 nm cut-off. The long-range electrostatic interactions were calculated using the PME method, 
with a cut-off for the real space term of 0.9 nm. Covalent bonds were constrained using the LINCS algorithm47. 
The time step employed was 2 fs, and the coordinates were saved every 2 ps for analysis, which was performed 
using standard GROMACS tools. The resultant trajectories were then subjected to analysis with the help of utilities 
available in the Gromacs package. g_rms, g_hbond, g_rmsf, and g_sas were used to calculate the root mean square 
deviation (RMSD), number of hydrogen bonds formed, root mean square fluctuation (RMSF), and solvent acces-
sible surface area (SASA), respectively. The results of the analysis were graphically represented using the GRACE 
software. PyMOL48, a molecular visualization tool was also used for representing structural changes of the protein.
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